Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Carcinoma, Renal Cell 1Acute Kidney Injury 1

Interventions

pembrolizumab 182Magnetic Resonance Spectroscopy 162Specimen Handling 135enzalutamide 126Nivolumab 124Gemcitabine 99Docetaxel 96Radiosurgery 92Prednisone 85Androgen Antagonists 82Abiraterone Acetate 81Radiotherapy 75apalutamide 68Cisplatin 65darolutamide 63Ipilimumab 63Biopsy 61abiraterone 58cabozantinib 56Carboplatin 56Leuprolide 53enfortumab vedotin 50Radiation 48Pluvicto 45Standard of Care 44atezolizumab 41Surveys and Questionnaires 39acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 37X-Rays 37avelumab 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ischemic Preconditioning × Genitourinary × 1 year × Clear all
NCT07497958 2026-03-27

Ischemic Preconditioning Reduces the Severity of Acute Kidney Injury After Partial Nephrectomy

Sun Yat-sen University

Phase NA Not yet recruiting
174 enrolled
Genitourinary

Carcinoma, Renal Cell, Acute Kidney Injury

Data powered by HemOnc (CC BY 4.0) Colophon âš¡